ASCO Study Shows Drug Novartis ® Afinitor first to shrink SEGA brain tumors in children and adults with tuberous … East Hanover, New Jersey, June 05 / PRNewswire / – Novartis Pharmaceuticals Corporation ("Novartis") announced today that the results of a Phase II study show Afinitor ® (Everolimus) tablets is the first drug in a clinical trial to reduce the size of subependymal giant cell astrocytomas (SEGAS), benign tumors the brain associated with tuberous sclerosis (TS) (1.2).
How to make a HOME-MADE mask to treat dry & acne prone skin